Michael Bongiorno Recognized as a 2021 Health Care/Life Science Trailblazer by The National Law Journal

Michael Bongiorno Recognized as a 2021 Health Care/Life Science Trailblazer by The National Law Journal

Recognition

Related Solutions

Clients across a range of industries turn to WilmerHale for sophisticated representation in high-stakes class action litigation.
Providing effective, creative and efficient representation for clients’ most complex commercial disputes.
Representing clients in sensitive inquiries across jurisdictions.
Guiding clients through high-stakes and sensitive investigations.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A global team handling highly complex and sensitive matters in all aspects of litigation.
WilmerHale has defended clients in hundreds of class, derivative, shareholder and individual actions alleging securities fraud, breach of fiduciary duty and other corporate misconduct.
WilmerHale has a record of success at all stages of enforcement proceedings—from informal inquiries to litigation.
Battle-tested. Globally Respected.

The National Law Journal (NLJ) named Michael Bongiorno, co-chair of WilmerHale’s Securities Litigation and Enforcement Practice, a 2021 Health Care/Life Science Trailblazer.

According to NLJ, Trailblazers are those who use new strategies and innovative approaches to move the needle in the legal industry and act as agents of change in their respective practice areas. Bongiorno was recognized for his work advising life sciences and biotechnology companies on disclosures surrounding clinical trials’ status and interactions with the Food and Drug Administration. In his feature profile, Bongiorno, who concentrates his practice on securities litigation and enforcement matters for biotech, life sciences and medical companies, noted that WilmerHale “has a long history of doing corporate work for innovative companies, with a large, robust corporate practice in Boston going back 100 years.”

 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel